Jennifer Good

Co-Founder, President & Chief Executive Officer at Trevi Therapeutics, Inc.

Jennifer Good

Jennifer Good

Co-Founder, President & Chief Executive Officer at Trevi Therapeutics, Inc.

Overview
Career Highlights

Penwest Pharmaceuticals Co.
Trevi Therapeutics, Inc.

RelSci Relationships

388

Number of Boards

6

Birthday

1965

Age

56

Number of Awards

1

Relationships
RelSci Relationships are individuals Jennifer Good likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman, President & Chief Executive Officer at Rhythm Pharmaceuticals, Inc.

Relationship likelihood: Strong

General Partner at New Enterprise Associates, Inc.

Relationship likelihood: Strong

Partner & Managing Director at TPG Biotech

Relationship likelihood: Strong

Vice President at TPG Biotech Equity LP

Relationship likelihood: Strong

Co-Founder at Trevi Therapeutics, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer (Phymatrix) at CSL Limited

Relationship likelihood: Strong

Scientific Director at Freidreich's Ataxia Research Alliance

Relationship likelihood: Strong

President, Director at Freidreich's Ataxia Research Alliance

Relationship likelihood: Strong

Chief Executive Officer at Lundbeckfonden Ventures

Relationship likelihood: Strong

Founder at Omega Fund Management LLC

Relationship likelihood: Strong

Paths to Jennifer Good
Potential Connections via
Relationship Science
You
Jennifer Good
Co-Founder, President & Chief Executive Officer at Trevi Therapeutics, Inc.
Education
Bachelor of Business Administration with a Concentration in Accounting
Class of 1987

Pacific Lutheran University (PLU) is a private university offering liberal arts and professional school programs located in Parkland, a suburb of Tacoma, Washington, United States. Founded by Norwegian Lutheran pioneers in 1890, PLU is sponsored by the 580 congregations of Region I of the Evangelical Lutheran Church in America. PLU has approximately 3,500 students enrolled. As of 2012 the school employs 236 full-time professors on the 156-acre (630,000 m2) woodland campus. PLU consists of the College of Arts and Sciences (including of the Divisions of Humanities, Natural Sciences, and Social Sciences), the School of Arts and Communication, the School of Business, the School of Education and Movement Studies, and the School of Nursing.

Career History
Co-Founder, President & Chief Executive Officer
2011 - Current

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Treasurer
Current

Newtown Youth and Family Services, is dedicated to helping children and families achieve their highest potential. Our vision is to become a recognized leader in providing mental health and support services.Our dynamic nonprofit agency combines clinical services and positive youth development programs to provide a continuum of care to residents of the greater Newtown area. We are a licensed, non-profit, mental health clinic and youth service bureau. We provide outpatient individual, couple and family counseling and substance abuse treatment services. In addition we offer prevention initiatives, after school, evening and weekend programs and support groups to promote individual and community wellness. In the wake of the December 14 tragedy, we have been declared the mental health agency for the town of Newtown.Newtown Youth and Family Services has proudly offered specialized programs and services to individuals of all ages for more than 30 years.

President & Chief Executive Officer
1997 - 2010

Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY.

Boards & Committees
Member, Board of Directors
Current

Karos Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The firm focuses on bone related, pulmonary arterial hypertension and other orphan diseases. The company was founded in 2009 and is headquartered in New Haven, CT.

Director
2008 - Prior

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its pipeline includes hCDR1 and Erythropoietin. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

Director
2011 - Current

TO TREAT AND CURE FRIEDREICH'S ATAXIA BY ADVANCING RESEARCH, AWARENESS AND PARTNERSHIPS.

Transactions
Details Hidden

Trevi Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Trevi Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Endo Health Solutions, Inc. purchases Penwest Pharmaceuticals Co.

Investments
Details Hidden

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
CPA (Certified Public Accountant)
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jennifer Good. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jennifer Good's profile does not indicate a business or promotional relationship of any kind between RelSci and Jennifer Good.